On March 10, 2020, Moleculin Biotech, Inc. announced that Dr. Hongbo Zhai, former Senior Faculty and Supervisor of Postdoctoral Fellows at University of California San Francisco, has joined Moleculin’s Science Advisory Board. As a former board-certified dermatologist in China, Dr. Hongbo Zhai has extensive experience with Chinese regulatory authorities including the CFDA and the Ministry of Public Health. Dr. Zhai has contributed to the development of products in collaboration with global Fortune 500 companies such as Procter & Gamble, Pfizer, Johnson & Johnson, 3M Pharmaceuticals, and L’OREAL and has published more than 120 scientific articles in his research areas.